![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, September 15, 2020 3:13:40 PM
Correct me if my thinking is incorrect.
The second quarter 10-Q being filed today is only showing the first full month revenues for the Covid-19 test kit which was June.
First quarter 10-Q, pre Corona virus, was poor. New drug tests and clients had not added to sales yet.
Second quarter, April would have been similar to Q-1 and been poor. May is when orders and shipping began. June put it all together with sales, shipping and revenues.
So if June did the heavy lifting we could extrapolate that it carried $600-800,000.00 of the sales quoted in today's PR.
Net sales in the second quarter of 2020 were $1,758,000, compared to net sales of $958,000 in the second quarter of 2019; an increase of $800,000, or 83.5%. Net sales in the six months ended June 30, 2020 were $2,486,000, compared to $1,880,000 in the six months ended June 30, 2019; an increase of $606,000, or 32.2%.
Third quarter sales can be in the millions per month going forward. The company is now geared up for receiving, shipping and sales.
We should get incredible revenue numbers stated through September 15 when the 10-Q is filed later today.
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM